About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

US Supreme Court to Consider Case on Bayer's Anti-cholesterol Drug

by VR Sreeraman on September 29, 2010 at 12:40 PM
Font : A-A+

 US Supreme Court to Consider Case on Bayer's Anti-cholesterol Drug

The US Supreme Court will take up a case filed by alleged victims of the anti-cholesterol drug Baycol seeking a class-action suit, after the drug was taken off the market in 2001 by German pharmaceuticals giant Bayer.

Baycol went on the US market in 1997 and was blamed for the deaths of 31 Americans four years later due to side effects including fatal muscle toxicity leading to kidney failure.

Advertisement

Several cases lodged over the drug, also known by its chemical name cerivastatin, were put together in a federal court in Minnesota but in the case delivered to the high court the plaintiffs were from West Virginia.

They are seeking damages for the financial hardship they say they faced due to the effects of the drug.

Bayer, however, argues that their class-action suit cannot proceed because the judge in charge of cases in Minnesota banned such suits, also sought by West Virginia plaintiffs, back in August 2005.

The nine Supreme Court justices will review the case in early 2011 and rule by June at the latest.

Source: AFP
Advertisement
Advertisement
Advertisement

Recommended Reading

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

US Supreme Court to Consider Case on Bayer's Anti-cholesterol Drug Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests